| Date | Event | Description |
|---|---|---|
| 6 March 2021 | New citation required but conclusions have not changed | Updated searches from new authorship team ‐ prior review updated. |
| 6 March 2021 | New search has been performed | We included 11 studies involving 42,226 participants. Three new trials have been added since the last update. As per the previous version of this review, two trials testing aspirin 160 mg to 300 mg once daily, started within 48 hours of onset, contributed 96% of the data. The risk of bias was low. The maximum follow‐up was six months. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.